Items where authors include "Yap, C"

Article

Love, SB, Cafferty, F, Snowdon, C et al. (33 more authors) (2022) Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units. Trials, 23 (1). p. 757. ISSN 1745-6215

Doherty, B, Bryant, M, Denby, K et al. (19 more authors) (2022) Transformations to regenerative food systems-An outline of the FixOurFood project. Nutrition Bulletin, 47 (1). pp. 106-114. ISSN 1467-3010

Aad, G, Abbott, B, Abbott, DC et al. (2840 more authors) (2021) Performance of the ATLAS RPC detector and Level-1 muon barrel trigger at √(s)=13 TeV. Journal of Instrumentation, 16 (7). P07029.

Pratt, AG, Siebert, S, Cole, M et al. (13 more authors) (2021) Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial. The Lancet Rheumatology, 3 (5). e337-e346. ISSN 2665-9913

Pettitt, AR, Jackson, R, Cicconi, S et al. (23 more authors) (2020) Lenalidomide, Dexamethasone And Alemtuzumab Or Ofatumumab In High-Risk Chronic Lymphocytic Leukaemia: Final Results Of The NCRI CLL210 Trial. Haematologica, 105 (12). pp. 2868-2871. ISSN 0390-6078

Newsome, PN, Fox, R, King, AL et al. (19 more authors) (2018) Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial. The Lancet Gastroenterology & Hepatology, 3 (1). pp. 25-36. ISSN 2468-1253

Love, SB, Brown, S, Weir, CJ et al. (10 more authors) (2017) Embracing model-based designs for dose-finding trials. British Journal of Cancer, 117 (3). pp. 332-339. ISSN 0007-0920